1-5 of 5
Renato Zambello, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD Compared to TD.

Michele Cavo, M.D., Paola Tacchetti, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Lucia Pantani, M.D., Monica Galli, M.D., Francesco Di Raimondo, M.D., Claudia Crippa, M.D., Sara Bringhen, M.D., Massimo Offidani, M.D., Franco Narni, M.D., Vittorio Montefusco, M.D., Elena Zamagni, M.D., Tonino Spadano, M.D., Norbert Pescosta, M.D., Luca Baldini, M.D., Claudia Cellini, M.D., Tommaso Caravita, M.D., Antonio Ledda, M.D., Antonietta Falcone, M.D., Patrizia Tosi, M.D., Chiara Nozzoli, M.D., Renato Zambello, M.D., Luciano Masini, M.D., Paola Agostini, M.D., Mauro Fiacchini, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2009) 114 (22): 351.
https://doi.org/10.1182/blood.V114.22.351.351
Published: 2009
Journal Articles

A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens

Michele Cavo, MD, Antonio Palumbo, M.D., Sara Bringhen, M.D., Antonietta Falcone, M.D., Pellegrino Musto, M.D., Fabio Ciceri, M.D., Mariella Grasso, M.D., Renato Zambello, M.D., Maria Concetta Petti, M.D., Fabrizio Ciambelli, M.D., Giovanni De Sabbata, M.D., Stefano Rocco, M.D., Luigi Gugliotta, M.D., Filippo Gherlinzoni, M.D., Alfonso D’Arco, M.D., Massimo Martelli, M.D., Tommasina Guglielmelli, M.D., Paola Tacchetti, M.D., Michele Baccarani, M.D., Mario Boccadoro
Journal: Blood
Blood (2008) 112 (11): 3017.
https://doi.org/10.1182/blood.V112.11.3017.3017
Published: 2008
Journal Articles

Superior Rate of Complete Response with up-Front Velcade-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma Is Not Affected by Adverse Prognostic Factors, Including High-Risk Cytogenetic Abnormalities.

Michele Cavo, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Giulia Marzocchi, B.S., Sandra Durante, B.S., Renato Zambello, M.D., Chiara Nozzoli, M.D., Lucia Pantani, M.D., Paola Tacchetti, M.D., Luciano Masini, M.D., Michela Ceccolini, M.D., Paola Agostini, M.D., Elena Zamagni, M.D., Valerio De Stefano, M.D., Patrizia Tosi, M.D., Daniele Derudas, M.D., Laura Dessanti, M.D., Stelvio Ballanti, M.D., Salvatore Palmieri, M.D., Andrea Nozza, M.D., Gioacchino Catania, M.D., Jacopo Peccatori, M.D., Alfonso D’Arco, M.D., Pellegrino Musto, M.D., Mariella Grasso, M.D., Maria Caterina Pallotti, M.D., Silvana Pasini, M.D., Pier Paolo Fattori, M.D., Anna Baraldi, M.D., Delia Cangini, M.D., Filippo Ballerini, M.D., Alessandro Petrucci, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 1662.
https://doi.org/10.1182/blood.V112.11.1662.1662
Published: 2008
Journal Articles

Pleiotropic Role of GSK3 Kinase in Myeloma Cell Biology.

Francesco A. Piazza, MD, Carmela Gurrieri, M.D., Gino Chioetto, Ph.D., Luca Bonanni, M.D., Barbara Montini, Ph.D., Samuela Carraro, Ph.D., Anna Cabrelle, Ph.D., Renato Zambello, M.D., Livio Trentin, M.D., Fausto Adami, M.D., Gianpietro Semenzato, M.D.
Journal: Blood
Blood (2006) 108 (11): 4995.
https://doi.org/10.1182/blood.V108.11.4995.4995
Published: 2006
Journal Articles

Multiple Myeloma Cells Survival and Proliferation Rely on High Levels and Activity of the Serine-Threonine Kinase CK2.

Francesco A. Piazza, M.D., Maria Ruzzene, Ph.D., Giovanni Di Maira, Ph.D., Enrico Brunetta, M.D., Luca Bonanni, M.D., Livio Trentin, M.D., Renato Zambello, M.D., Lorenzo A. Pinna, Ph.D., Gianpietro Semenzato, M.D.
Journal: Blood
Blood (2004) 104 (11): 643.
https://doi.org/10.1182/blood.V104.11.643.643
Published: 2004